000 00988 a2200265 4500
005 20250514162926.0
264 0 _c20040106
008 200401s 0 0 eng d
022 _a0190-9622
024 7 _a10.1016/s0190-9622(03)02161-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStashower, Mitchell E
245 0 0 _aPregnancy rates associated with isotretinoin (Accutane) and the FDA.
_h[electronic resource]
260 _bJournal of the American Academy of Dermatology
_cDec 2003
300 _a1202-3 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aDermatologic Agents
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIsotretinoin
_xadverse effects
650 0 4 _aPregnancy
_xdrug effects
650 0 4 _aPregnancy, Unwanted
773 0 _tJournal of the American Academy of Dermatology
_gvol. 49
_gno. 6
_gp. 1202-3
856 4 0 _uhttps://doi.org/10.1016/s0190-9622(03)02161-3
_zAvailable from publisher's website
999 _c14374497
_d14374497